Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Finasteride may cause gum problems, but stopping the drug can improve these issues.

Levothyroxine effectively treated a dog's skin and hair problems caused by hypothyroidism.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

New cytokine-targeted therapies show promise for treating alopecia areata.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.